カテゴリ： 世界, IT/電子, QYResearch

経口メサラジンの世界市場2023年：錠剤、カプセル、顆粒

■ 英語タイトル：Global Oral Mesalazine Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8837）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8837
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：87
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[経口メサラジンの世界市場2023年：錠剤、カプセル、顆粒]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は経口メサラジンのグローバル市場について調査・分析し、世界の経口メサラジン市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（錠剤、カプセル、顆粒）、用途別セグメント分析（潰瘍性大腸炎、クローン病、炎症性腸疾患、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、AbbVie、Shire、Salix Pharmaceuticals、Ferring Global、Teva Pharmaceutical Industries、Morningside Healthcare、Dr. Falk Pharma UK、Nogra Pharma Limited、Tillotts Pharmaなどが含まれています。経口メサラジンのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、経口メサラジン市場規模を算出する際に考慮しました。

・経口メサラジン市場の概要
- 経口メサラジンの種類別セグメント
- 世界の経口メサラジン市場規模：タイプ別分析（錠剤、カプセル、顆粒）
- 経口メサラジンの用途別セグメント
- 世界の経口メサラジン市場規模：用途別分析（潰瘍性大腸炎、クローン病、炎症性腸疾患、その他）
- 世界の経口メサラジン市場規模予測（2018年-2029年）

・経口メサラジン市場の成長トレンド
- 経口メサラジンの地域別市場規模（2018年-2029年）
- 経口メサラジン市場ダイナミクス
- 経口メサラジンの業界動向
- 経口メサラジン市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：錠剤、カプセル、顆粒
- 世界の経口メサラジンのタイプ別市場規模（2018年-2023年）
- 世界の経口メサラジンのタイプ別市場規模（2024年-2029年）

・用途別セグメント：潰瘍性大腸炎、クローン病、炎症性腸疾患、その他
- 世界の経口メサラジンの用途別市場規模（2018年-2023年）
- 世界の経口メサラジンの用途別市場規模（2024年-2029年）

・経口メサラジンの地域別市場規模
- 北米の経口メサラジン市場規模（2018年-2029年）
- 米国の経口メサラジン市場規模（2018年-2029年）
- ヨーロッパの経口メサラジン市場規模（2018年-2029年）
- アジア太平洋の経口メサラジン市場規模（2018年-2029年）
- 中国の経口メサラジン市場規模（2018年-2029年）
- 日本の経口メサラジン市場規模（2018年-2029年）
- 韓国の経口メサラジン市場規模（2018年-2029年）
- インドの経口メサラジン市場規模（2018年-2029年）
- オーストラリアの経口メサラジン市場規模（2018年-2029年）
- 中南米の経口メサラジン市場規模（2018年-2029年）
- 中東・アフリカの経口メサラジン市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
AbbVie、Shire、Salix Pharmaceuticals、Ferring Global、Teva Pharmaceutical Industries、Morningside Healthcare、Dr. Falk Pharma UK、Nogra Pharma Limited、Tillotts Pharma

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Oral Mesalazine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Oral Mesalazine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Oral Mesalazine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Oral Mesalazine in Ulcerative Colitis is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Oral Mesalazine include AbbVie, Shire, Salix Pharmaceuticals, Ferring Global, Teva Pharmaceutical Industries, Morningside Healthcare, Dr. Falk Pharma UK, Nogra Pharma Limited and Tillotts Pharma, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Mesalazine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Mesalazine.
The Oral Mesalazine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Oral Mesalazine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Mesalazine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
AbbVie
Shire
Salix Pharmaceuticals
Ferring Global
Teva Pharmaceutical Industries
Morningside Healthcare
Dr. Falk Pharma UK
Nogra Pharma Limited
Tillotts Pharma
Segment by Type
Tablets
Capsules
Granule
Segment by Application
Ulcerative Colitis
Crohn’s Disease
Inflammatory Bowel Disease
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Mesalazine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Mesalazine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Granule
1.3 Market by Application
1.3.1 Global Oral Mesalazine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Ulcerative Colitis
1.3.3 Crohn’s Disease
1.3.4 Inflammatory Bowel Disease
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Mesalazine Market Perspective (2018-2029)
2.2 Oral Mesalazine Growth Trends by Region
2.2.1 Global Oral Mesalazine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral Mesalazine Historic Market Size by Region (2018-2023)
2.2.3 Oral Mesalazine Forecasted Market Size by Region (2024-2029)
2.3 Oral Mesalazine Market Dynamics
2.3.1 Oral Mesalazine Industry Trends
2.3.2 Oral Mesalazine Market Drivers
2.3.3 Oral Mesalazine Market Challenges
2.3.4 Oral Mesalazine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Mesalazine Players by Revenue
3.1.1 Global Top Oral Mesalazine Players by Revenue (2018-2023)
3.1.2 Global Oral Mesalazine Revenue Market Share by Players (2018-2023)
3.2 Global Oral Mesalazine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Mesalazine Revenue
3.4 Global Oral Mesalazine Market Concentration Ratio
3.4.1 Global Oral Mesalazine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Mesalazine Revenue in 2022
3.5 Oral Mesalazine Key Players Head office and Area Served
3.6 Key Players Oral Mesalazine Product Solution and Service
3.7 Date of Enter into Oral Mesalazine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Mesalazine Breakdown Data by Type
4.1 Global Oral Mesalazine Historic Market Size by Type (2018-2023)
4.2 Global Oral Mesalazine Forecasted Market Size by Type (2024-2029)
5 Oral Mesalazine Breakdown Data by Application
5.1 Global Oral Mesalazine Historic Market Size by Application (2018-2023)
5.2 Global Oral Mesalazine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral Mesalazine Market Size (2018-2029)
6.2 North America Oral Mesalazine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oral Mesalazine Market Size by Country (2018-2023)
6.4 North America Oral Mesalazine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Mesalazine Market Size (2018-2029)
7.2 Europe Oral Mesalazine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oral Mesalazine Market Size by Country (2018-2023)
7.4 Europe Oral Mesalazine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Mesalazine Market Size (2018-2029)
8.2 Asia-Pacific Oral Mesalazine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oral Mesalazine Market Size by Region (2018-2023)
8.4 Asia-Pacific Oral Mesalazine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Mesalazine Market Size (2018-2029)
9.2 Latin America Oral Mesalazine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oral Mesalazine Market Size by Country (2018-2023)
9.4 Latin America Oral Mesalazine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Mesalazine Market Size (2018-2029)
10.2 Middle East & Africa Oral Mesalazine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oral Mesalazine Market Size by Country (2018-2023)
10.4 Middle East & Africa Oral Mesalazine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Oral Mesalazine Introduction
11.1.4 AbbVie Revenue in Oral Mesalazine Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Shire
11.2.1 Shire Company Detail
11.2.2 Shire Business Overview
11.2.3 Shire Oral Mesalazine Introduction
11.2.4 Shire Revenue in Oral Mesalazine Business (2018-2023)
11.2.5 Shire Recent Development
11.3 Salix Pharmaceuticals
11.3.1 Salix Pharmaceuticals Company Detail
11.3.2 Salix Pharmaceuticals Business Overview
11.3.3 Salix Pharmaceuticals Oral Mesalazine Introduction
11.3.4 Salix Pharmaceuticals Revenue in Oral Mesalazine Business (2018-2023)
11.3.5 Salix Pharmaceuticals Recent Development
11.4 Ferring Global
11.4.1 Ferring Global Company Detail
11.4.2 Ferring Global Business Overview
11.4.3 Ferring Global Oral Mesalazine Introduction
11.4.4 Ferring Global Revenue in Oral Mesalazine Business (2018-2023)
11.4.5 Ferring Global Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Detail
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Oral Mesalazine Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Oral Mesalazine Business (2018-2023)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 Morningside Healthcare
11.6.1 Morningside Healthcare Company Detail
11.6.2 Morningside Healthcare Business Overview
11.6.3 Morningside Healthcare Oral Mesalazine Introduction
11.6.4 Morningside Healthcare Revenue in Oral Mesalazine Business (2018-2023)
11.6.5 Morningside Healthcare Recent Development
11.7 Dr. Falk Pharma UK
11.7.1 Dr. Falk Pharma UK Company Detail
11.7.2 Dr. Falk Pharma UK Business Overview
11.7.3 Dr. Falk Pharma UK Oral Mesalazine Introduction
11.7.4 Dr. Falk Pharma UK Revenue in Oral Mesalazine Business (2018-2023)
11.7.5 Dr. Falk Pharma UK Recent Development
11.8 Nogra Pharma Limited
11.8.1 Nogra Pharma Limited Company Detail
11.8.2 Nogra Pharma Limited Business Overview
11.8.3 Nogra Pharma Limited Oral Mesalazine Introduction
11.8.4 Nogra Pharma Limited Revenue in Oral Mesalazine Business (2018-2023)
11.8.5 Nogra Pharma Limited Recent Development
11.9 Tillotts Pharma
11.9.1 Tillotts Pharma Company Detail
11.9.2 Tillotts Pharma Business Overview
11.9.3 Tillotts Pharma Oral Mesalazine Introduction
11.9.4 Tillotts Pharma Revenue in Oral Mesalazine Business (2018-2023)
11.9.5 Tillotts Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Oral Mesalazine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Tablets
Table 3. Key Players of Capsules
Table 4. Key Players of Granule
Table 5. Global Oral Mesalazine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Oral Mesalazine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Oral Mesalazine Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Oral Mesalazine Market Share by Region (2018-2023)
Table 9. Global Oral Mesalazine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Oral Mesalazine Market Share by Region (2024-2029)
Table 11. Oral Mesalazine Market Trends
Table 12. Oral Mesalazine Market Drivers
Table 13. Oral Mesalazine Market Challenges
Table 14. Oral Mesalazine Market Restraints
Table 15. Global Oral Mesalazine Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Oral Mesalazine Market Share by Players (2018-2023)
Table 17. Global Top Oral Mesalazine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Mesalazine as of 2022)
Table 18. Ranking of Global Top Oral Mesalazine Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Oral Mesalazine Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Oral Mesalazine Product Solution and Service
Table 22. Date of Enter into Oral Mesalazine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Oral Mesalazine Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Oral Mesalazine Revenue Market Share by Type (2018-2023)
Table 26. Global Oral Mesalazine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Oral Mesalazine Revenue Market Share by Type (2024-2029)
Table 28. Global Oral Mesalazine Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Oral Mesalazine Revenue Market Share by Application (2018-2023)
Table 30. Global Oral Mesalazine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Oral Mesalazine Revenue Market Share by Application (2024-2029)
Table 32. North America Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Oral Mesalazine Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Oral Mesalazine Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Oral Mesalazine Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Oral Mesalazine Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Oral Mesalazine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Oral Mesalazine Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Oral Mesalazine Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Oral Mesalazine Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Oral Mesalazine Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Oral Mesalazine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Oral Mesalazine Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Oral Mesalazine Market Size by Country (2024-2029) & (US$ Million)
Table 47. AbbVie Company Detail
Table 48. AbbVie Business Overview
Table 49. AbbVie Oral Mesalazine Product
Table 50. AbbVie Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 51. AbbVie Recent Development
Table 52. Shire Company Detail
Table 53. Shire Business Overview
Table 54. Shire Oral Mesalazine Product
Table 55. Shire Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 56. Shire Recent Development
Table 57. Salix Pharmaceuticals Company Detail
Table 58. Salix Pharmaceuticals Business Overview
Table 59. Salix Pharmaceuticals Oral Mesalazine Product
Table 60. Salix Pharmaceuticals Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 61. Salix Pharmaceuticals Recent Development
Table 62. Ferring Global Company Detail
Table 63. Ferring Global Business Overview
Table 64. Ferring Global Oral Mesalazine Product
Table 65. Ferring Global Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 66. Ferring Global Recent Development
Table 67. Teva Pharmaceutical Industries Company Detail
Table 68. Teva Pharmaceutical Industries Business Overview
Table 69. Teva Pharmaceutical Industries Oral Mesalazine Product
Table 70. Teva Pharmaceutical Industries Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 71. Teva Pharmaceutical Industries Recent Development
Table 72. Morningside Healthcare Company Detail
Table 73. Morningside Healthcare Business Overview
Table 74. Morningside Healthcare Oral Mesalazine Product
Table 75. Morningside Healthcare Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 76. Morningside Healthcare Recent Development
Table 77. Dr. Falk Pharma UK Company Detail
Table 78. Dr. Falk Pharma UK Business Overview
Table 79. Dr. Falk Pharma UK Oral Mesalazine Product
Table 80. Dr. Falk Pharma UK Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 81. Dr. Falk Pharma UK Recent Development
Table 82. Nogra Pharma Limited Company Detail
Table 83. Nogra Pharma Limited Business Overview
Table 84. Nogra Pharma Limited Oral Mesalazine Product
Table 85. Nogra Pharma Limited Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 86. Nogra Pharma Limited Recent Development
Table 87. Tillotts Pharma Company Detail
Table 88. Tillotts Pharma Business Overview
Table 89. Tillotts Pharma Oral Mesalazine Product
Table 90. Tillotts Pharma Revenue in Oral Mesalazine Business (2018-2023) & (US$ Million)
Table 91. Tillotts Pharma Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Mesalazine Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Oral Mesalazine Market Share by Type: 2022 VS 2029
Figure 3. Tablets Features
Figure 4. Capsules Features
Figure 5. Granule Features
Figure 6. Global Oral Mesalazine Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Oral Mesalazine Market Share by Application: 2022 VS 2029
Figure 8. Ulcerative Colitis Case Studies
Figure 9. Crohn's Disease Case Studies
Figure 10. Inflammatory Bowel Disease Case Studies
Figure 11. Others Case Studies
Figure 12. Oral Mesalazine Report Years Considered
Figure 13. Global Oral Mesalazine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Oral Mesalazine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oral Mesalazine Market Share by Region: 2022 VS 2029
Figure 16. Global Oral Mesalazine Market Share by Players in 2022
Figure 17. Global Top Oral Mesalazine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Mesalazine as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oral Mesalazine Revenue in 2022
Figure 19. North America Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Oral Mesalazine Market Share by Country (2018-2029)
Figure 21. United States Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Oral Mesalazine Market Share by Country (2018-2029)
Figure 25. Germany Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Oral Mesalazine Market Share by Region (2018-2029)
Figure 33. China Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Oral Mesalazine Market Share by Country (2018-2029)
Figure 41. Mexico Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Oral Mesalazine Market Share by Country (2018-2029)
Figure 45. Turkey Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Oral Mesalazine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 48. Shire Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 49. Salix Pharmaceuticals Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 50. Ferring Global Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 52. Morningside Healthcare Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 53. Dr. Falk Pharma UK Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 54. Nogra Pharma Limited Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 55. Tillotts Pharma Revenue Growth Rate in Oral Mesalazine Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 關心蘇河膠廠のグローバル市場展望 2023年-2029年：0.35g/カプセル、0.25g/カプセル
  • アカルボース医薬品の世界市場2023年：錠剤、カプセル
  • レボドパ＆ベンセラジド塩酸塩の世界市場2023年：カプセル、錠剤、顆粒
  • トラマドール医薬品のグローバル市場展望 2023年-2029年：錠剤、カプセル、液体、懸濁液、その他
  • UDCA（ウルソデオキシコール酸）薬剤のグローバル市場展望 2023年-2029年：カプセル、錠剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8837 )"経口メサラジンの世界市場2023年：錠剤、カプセル、顆粒" (英文：Global Oral Mesalazine Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。